Cardinal Capital Management Inc (Canada)’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$35.4M Sell
190,773
-6,840
-3% -$1.27M 1.11% 27
2025
Q1
$41.4M Buy
197,613
+289
+0.1% +$60.6K 1.41% 22
2024
Q4
$35.1M Sell
197,324
-103
-0.1% -$18.3K 1.19% 26
2024
Q3
$39M Buy
197,427
+588
+0.3% +$116K 1.61% 15
2024
Q2
$33.8M Buy
196,839
+348
+0.2% +$59.7K 1.3% 19
2024
Q1
$35.8M Sell
196,491
-3,561
-2% -$648K 1.59% 18
2023
Q4
$31M Buy
200,052
+525
+0.3% +$81.4K 1.47% 19
2023
Q3
$29.7M Buy
199,527
+1,447
+0.7% +$216K 1.55% 19
2023
Q2
$26.7M Buy
198,080
+420
+0.2% +$56.6K 1.34% 25
2023
Q1
$31.5M Buy
197,660
+24,546
+14% +$3.91M 1.71% 16
2022
Q4
$28M Buy
173,114
+5,282
+3% +$854K 1.58% 18
2022
Q3
$22.5M Buy
167,832
+3,960
+2% +$531K 1.37% 17
2022
Q2
$25.1M Buy
163,872
+11,777
+8% +$1.8M 1.39% 16
2022
Q1
$24.7M Buy
152,095
+137,885
+970% +$22.4M 1.2% 22
2021
Q4
$1.92M Buy
14,210
+150
+1% +$20.3K 0.09% 45
2021
Q3
$1.52M Buy
14,060
+2,233
+19% +$241K 0.08% 43
2021
Q2
$1.33M Buy
11,827
+202
+2% +$22.8K 0.07% 44
2021
Q1
$1.26M Buy
11,625
+1,425
+14% +$154K 0.07% 44
2020
Q4
$1.09M Buy
10,200
+445
+5% +$47.7K 0.07% 47
2020
Q3
$854K Buy
9,755
+465
+5% +$40.7K 0.06% 48
2020
Q2
$912K Buy
9,290
+2,105
+29% +$207K 0.08% 43
2020
Q1
$547K Buy
7,185
+6,530
+997% +$497K 0.05% 48
2019
Q4
$58K Buy
+655
New +$58K ﹤0.01% 55